This section of the review enumerates the possible therapeutic mechanisms for AD of metformin, GLP-1 receptor agonists, DPP4 inhibitors, insulin, and SGLT2 inhibitors, all of which are widely applied to patients with diabetes according to official Clinical Guidelines. This evidence concerns the gene GLP1R and diabetes mellitus.